The present research is based on the analysis of 500 patients with liver cirrhosis with complicated portal hypertension. All patients were examined and operated in the department of portal hypertension and pancreatic-duodenal zone surgery of acad. V. Vakhidov Republican Specialized Surgery Centre (Tashkent) during the period of 1976 - January 2007, included. The appreciation of survival rate curve in patients with liver cirrhosis after portal-systemic shunting is given on the basis of the prognosis factors stratification, that predetermines individual approach to each patient in the choice of surgical tactics and rehabilitation actions. We have mostly studied results and efficacy of different variants of portal-systemic shunting in stratificated groups, that allowed to reveal the most favourable group of patients with LC in respect of long-term prognosis after portal-systemic shunting.
Треть всех пациентов с циррозом печени ( ЦП) и варикозно расширенными венами пищевода и желудка (ВРВПЖ) продолжают умирать от пищеводно желу дочного кровотечения. Даже ведущие медицинские уч реждения добиваются снижения летальности от гемор рагического синдрома лишь до 30% [1,2,4], а в группе пациентов, соответствующей функциональному классу Child «С», летальность достигает 100% [2].Ранее проведенные исследования показали, что пи щеводное кровотечение может развиваться у 30-70% па циентов с ЦП, причем у 80% оно рецидивирует и 60-70% из них умирают в течение одного года [3,5].
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.